Reports for TEVA CANADA LIMITED
Company Name
TEVA CANADA LIMITED
Totals |
||
Shortage reports |
2681 |
|
Actual shortage: | 255 (10%) | |
Anticipated shortage: | 0 (0%) | |
Avoided shortage: | 9 (0%) | |
Resolved: | 2417 (90%) | |
Discontinuation Reports |
250 |
|
To be discontinued: | 3 (1%) | |
Discontinued: | 247 (99%) | |
Reversed: | 0 (0%) | |
Late reports |
330 (11%) |
|
Overdue reports |
23 (9%) |
Shortage reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
TEVA-OXYCOCET | 5MG 325MG | TABLET | Resolved | 2020-07-16 | 2020-09-25 | 120453 |
TEVA-OXYCOCET | 5MG 325MG | TABLET | Resolved | 2021-01-07 | 2021-02-05 | 131078 |
TEVA-OXYCOCET | 5MG 325MG | TABLET | Resolved | 2021-03-25 | 2021-04-08 | 136304 |
TEVA-OXYCODAN | 5MG 325MG | TABLET | Resolved | 2022-03-04 | 2022-03-09 | 156067 |
TEVA-CILAZAPRIL/HCTZ | 5MG 12.5MG | TABLET | Resolved | 2020-10-22 | 2021-04-29 | 126948 |
TEVA-LIOTHYRONINE | 5MCG | TABLET | Resolved | 2021-06-10 | 2021-07-09 | 140684 |
TEVA-LIOTHYRONINE | 5MCG | TABLET | Resolved | 2021-12-02 | 2022-01-20 | 150400 |
AERMONY RESPICLICK | 55MCG | POWDER (METERED DOSE) | Resolved | 2022-12-01 | 2023-01-18 | 176791 |
TEVA-NAPROXEN SODIUM DS | 550MG | TABLET | Resolved | 2020-04-03 | 2020-04-09 | 110752 |
TEVA-NAPROXEN SODIUM DS | 550MG | TABLET | Resolved | 2020-06-25 | 2020-07-23 | 118954 |
TEVA-NAPROXEN SODIUM DS | 550MG | TABLET | Resolved | 2021-01-22 | 2021-03-18 | 132257 |
TEVA-NAPROXEN SODIUM DS | 550MG | TABLET | Resolved | 2022-05-05 | 2022-06-04 | 160072 |
TEVA-NAPROXEN SODIUM DS | 550MG | TABLET | Resolved | 2023-10-19 | 2023-11-09 | 207509 |
TEVA-METHYLPHENIDATE ER-C | 54MG | TABLET (EXTENDED-RELEASE) | Actual shortage | 2017-11-24 | 2020-01-21 | 30691 |
ACT METHYLPHENIDATE ER | 54MG | TABLET (EXTENDED-RELEASE) | Resolved | 2018-11-01 | 2024-02-13 | 65999 |
ACT METHYLPHENIDATE ER | 54MG | TABLET (EXTENDED-RELEASE) | Actual shortage | 2024-05-16 | 2024-05-16 | 228143 |
NOVO-HYDROXYZIN | 50MG | CAPSULE | Actual shortage | 2017-03-13 | 2020-02-13 | 1017 |
TEVA-QUETIAPINE XR | 50MG | TABLET (EXTENDED-RELEASE) | Resolved | 2017-03-13 | 2017-10-10 | 1778 |
TEVA-ATENOLOL | 50MG | TABLET | Resolved | 2017-03-13 | 2020-02-13 | 1797 |
TEVA-AMITRIPTYLINE | 50MG | TABLET | Resolved | 2017-03-14 | 2017-05-23 | 2434 |
Discontinuation reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
HYDROCORTISONE SODIUM SUCCINATE FOR INJECTION | Discontinued | 2019-04-11 | 2019-04-11 | 81337 | ||
HYDROCORTISONE SODIUM SUCCINATE FOR INJECTION | Discontinued | 2019-04-11 | 2019-04-11 | 81344 | ||
HYDROCORTISONE SODIUM SUCCINATE INJECTION | Discontinued | 2019-04-11 | 2019-04-11 | 81347 | ||
TEVA-RANITIDINE | Discontinued | 2020-02-13 | 2020-02-13 | 106136 | ||
TEVA-RANITIDINE | Discontinued | 2020-02-13 | 2020-02-13 | 106139 | ||
RATIO-SALBUTAMOL | Discontinued | 2020-02-13 | 2020-02-13 | 106151 | ||
GEMCITABINE FOR INJECTION | Discontinued | 2020-02-13 | 2020-02-13 | 106155 | ||
EPTIFIBATIDE INJECTION | Discontinued | 2020-02-13 | 2020-02-13 | 106170 | ||
LINEZOLID INJECTION | Discontinued | 2020-02-13 | 2020-02-13 | 106173 | ||
EPTIFIBATIDE INJECTION | Discontinued | 2020-02-13 | 2020-02-13 | 106176 |